Saving lives by fighting infection
Close

Search the BSAC site

News & Views

Responding to developments | Cutting through the noise | Promoting diverse voices | Shaping opinion | Making connections | Pointing to the evidence

Antibiotic Resistance: Is the Western emphasis on stewardship misplaced?

4th June 2020

While successful antibiotic stewardship programmes may make some impact in countries with good sanitation standards, Dr Abdul Ghafur, coordinator of the Chennai Declaration, is doubtful whether it will make any substantial difference to superbug rates in developing countries...

BSAC calls for further life-saving support after $1million invested in its COVID-19 R&D fund

2nd June 2020

The British Society for Antimicrobial Chemotherapy (BSAC) has urged other companies and major donors to boost coronavirus (COVID-19) research and development after pharmaceutical company Pfizer awarded $1million to its grants programme.

Focusing on a brighter future: How an ultra-low-cost 3D printed microscope could revolutionise healthcare in LMICs

2nd June 2020

Access to quality-assured laboratory diagnosis has long been a challenge in low-income and middle-income countries (LMICs) resulting in delayed or inaccurate diagnosis and ineffective treatment. But innovative approaches to design are helping to reduce the cost and availability of life-saving equipment...

BSAC invite expressions of interest to adopt invaluable isolate collection

2nd June 2020

After careful consideration and extended discussions, BSAC Council has taken the decision to close our flagship Antimicrobial Resistance Surveillance Programme, and are inviting expressions of interest from academic or not-for-profit organisations who may be interested in adopting all/part of the isolate collection, which contains almost 100,000 isolates from a range of clinically significant species.

BSAC joins forces with development bank to stop superbugs

2nd June 2020

The British Society for Antimicrobial Chemotherapy (BSAC) has formally partnered with the European Bank for Reconstruction and Development (EBRD) in a bid to tackle antimicrobial resistance.

COVID-19: Our dysfunctional relationship with nature leaves the door open to deadlier pandemics

26th May 2020

It has been estimated that as many as 70% of emerging diseases come from our contact with animals. As such, plans to prepare for future pandemics must surely focus on shifting to a less exploitative relationship with nature and the environment...

The new normal: post-pandemic, could the tools we are using to fight COVID-19 also help us tackle the spread of superbugs?

19th May 2020

In response to the COVID-19 pandemic, the Outpatient Parenteral Antimicrobial Therapy (OPAT) team at Wythenshawe Hospital, in Manchester, UK, utilised its skills in assessing patients remotely to develop a COVID-19 Virtual Ward. Lead Nurse, Liz Wilson, explains the process and considers how these experiences could instruct best practice in the future...

Antibiotic resistance: the ‘other’ pandemic lurking behind COVID-19

12th May 2020

Antibiotic resistance is a slow-motion pandemic – whose speed will increase because of COVID-19. A concentrated global effort is now needed to ensure it is addressed with the same urgency that’s likely to bring us a COVID-19 vaccine in the months ahead...

1 2 3
GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top